Biostage, Inc. 4
4 · Biostage, Inc. · Filed May 23, 2016
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
McNaughton Thomas
Chief Financial Officer
Transactions
- Purchase
Common Stock
2016-05-20$1.55/sh+2,500$3,875→ 206,128 total - Purchase
Common Stock
2016-05-20$1.56/sh+2,500$3,900→ 203,628 total
Footnotes (2)
- [F1]Includes (a) a deferred stock award of 268 restricted stock units which vest on January 1, 2017; and (b) 203,360 shares of common stock held by the Reporting Person.
- [F2]Includes (a) a deferred stock award of 268 restricted stock units which vest on January 1, 2017; and (b) 205,860 shares of common stock held by the Reporting Person.